Anthony Hollander is Pro-Vice-Chancellor for Research & Impact and Professor of Stem Cell Biology at the University of Liverpool.
He provides strategic leadership for the development of research policy and for ensuring impact of the University’s research programmes in Liverpool and around the world. He is also responsible for commercialisation of research, for developing partnerships with companies and other external stakeholders and for the training of postgraduate research students.
Anthony’s research career has focussed on the development of stem cell therapies for treating diseases of cartilage. His former University of Bristol spin-out company, Azellon Ltd, developed a stem cell treatment for torn knee cartilage and his new University of Liverpool spin-out company, TrophiCell, is developing trophic stem cell therapies for a range of chronic diseases. He was previously part of a team that created the world’s first tissue engineered airway and is former President of the International Cartilage Repair Society, Chair of Utrecht University’s International Scientific and Societal Advisory Board for Life Sciences and Chair of the Russell Group Pro-Vice-Chancellor’s Research Network.